Literature DB >> 27381028

Standardized Documentation in Pediatric Diabetology: Experience From Austria and Germany.

Sabine E Hofer1, Anke Schwandt2, Reinhard W Holl2.   

Abstract

This article gives a short summary of standardized documentation for pediatric diabetology from a European perspective. The approach chosen by the Austrian/German DPV (Diabetes Patienten Verlaufsdokumentation) group is detailed. The electronic health record used is briefly described, as are external benchmarking reports and national and international comparisons. Similar initiatives like the Hvidore study group, the SWEET initiative (Pediatric Diabetes: Working to Create Centers of Reference in Europe), and the T1DExchange (Type 1 Diabetes Exchange Registry) are compared to the DPV effort.
© 2016 Diabetes Technology Society.

Entities:  

Keywords:  benchmarking; diabetes mellitus; international comparison; quality improvement; standardized documentation

Mesh：

Year:  2016        PMID： 27381028      PMCID： PMC5032966          DOI： 10.1177/1932296816658057

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


  29 in total

1.  Disease-Specific Trends of Comorbidity Coding and Implications for Risk Adjustment in Hospital Administrative Data.

Authors:  Ulrike Nimptsch
Journal:  Health Serv Res       Date:  2015-10-07       Impact factor: 3.402

2.  Tracking of metabolic control from childhood to young adulthood in type 1 diabetes.

Authors:  Sabine E Hofer; Klemens Raile; Elke Fröhlich-Reiterer; Thomas Kapellen; Axel Dost; Joachim Rosenbauer; Jürgen Grulich-Henn; Reinhard W Holl
Journal:  J Pediatr       Date:  2014-08-20       Impact factor: 4.406

3.  Childhood onset diabetes--time trends and climatological factors.

Authors:  G Dahlquist; L Mustonen
Journal:  Int J Epidemiol       Date:  1994-12       Impact factor: 7.196

Review 4.  A pediatric diabetes toolbox for creating centres of reference.

Authors:  Karin Lange; Susan Klotmann; Heike Saßmann; Bärbel Aschemeier; Eva Wintergerst; Peter Gerhardsson; Olga Kordonouri; Agnieszka Szypowska; Thomas Danne
Journal:  Pediatr Diabetes       Date:  2012-09       Impact factor: 4.866

5.  The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study.

Authors:  N Chaturvedi; J M Stephenson; J H Fuller
Journal:  Diabetes Care       Date:  1995-06       Impact factor: 19.112

6.  The epidemiology of insulin-dependent diabetes mellitus (IDDM) in Finland and in northern Europe.

Authors:  H K Akerblom; A Reunanen
Journal:  Diabetes Care       Date:  1985 Sep-Oct       Impact factor: 19.112

7.  Childhood diabetes in the Nordic countries: a comparison of quality registries.

Authors:  Lena Hanberger; Niels Birkebaek; Ragnar Bjarnason; Ann Kristin Drivvoll; Anders Johansen; Torild Skrivarhaug; Arni V Thorsson; Ulf Samuelsson
Journal:  J Diabetes Sci Technol       Date:  2014-04-17

8.  Life expectancy of type 1 diabetic patients during 1997-2010: a national Australian registry-based cohort study.

Authors:  Lili Huo; Jessica L Harding; Anna Peeters; Jonathan E Shaw; Dianna J Magliano
Journal:  Diabetologia       Date:  2016-01-21       Impact factor: 10.122

Review 9.  Computer programs and datasheets. Initiative on quality control of the German Working-Group on Pediatric Diabetology.

Authors:  R W Holl
Journal:  Horm Res       Date:  1998

10.  Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study.

Authors:  J M Stephenson; J H Fuller; G C Viberti; A K Sjolie; R Navalesi
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122
View more
  13 in total

1.  Exploring Variation in Glycemic Control Across and Within Eight High-Income Countries: A Cross-sectional Analysis of 64,666 Children and Adolescents With Type 1 Diabetes.

Authors:  Dimitrios Charalampopoulos; Julia M Hermann; Jannet Svensson; Torild Skrivarhaug; David M Maahs; Karin Akesson; Justin T Warner; Reinhard W Holl; Niels H Birkebæk; Ann K Drivvoll; Kellee M Miller; Ann-Marie Svensson; Terence Stephenson; Sabine E Hofer; Siri Fredheim; Siv J Kummernes; Nicole Foster; Lena Hanberger; Rakesh Amin; Birgit Rami-Merhar; Anders Johansen; Knut Dahl-Jørgensen; Mark Clements; Ragnar Hanas
Journal:  Diabetes Care       Date:  2018-04-12       Impact factor: 19.112

2.  Fracture risk in patients with type 2 diabetes aged ≥50 years related to HbA1c, acute complications, BMI and SGLT2i-use in the DPV registry.

Authors:  Alexander J Eckert; Julia K Mader; Marcus Altmeier; Steffen Mühldorfer; Anton Gillessen; Dhayana Dallmeier; Viral N Shah; Christoph Heyer; Bettina Hartmann; Reinhard W Holl
Journal:  J Diabetes Complications       Date:  2020-06-27       Impact factor: 2.852

3.  Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.

Authors:  Beate Karges; Anke Schwandt; Bettina Heidtmann; Olga Kordonouri; Elisabeth Binder; Ulrike Schierloh; Claudia Boettcher; Thomas Kapellen; Joachim Rosenbauer; Reinhard W Holl
Journal:  JAMA       Date:  2017-10-10       Impact factor: 56.272

4.  Early vs late histological confirmation of coeliac disease in children with new-onset type 1 diabetes.

Authors:  Clemens Kamrath; Sascha R Tittel; Desiree Dunstheimer; Elke Fröhlich-Reiterer; Markus Freff; Claudia Böttcher; Nadine Scheffler; Stefanie Lenze; Elke Gericke; Susanne Thiele; Reinhard W Holl
Journal:  Diabetologia       Date:  2022-04-30       Impact factor: 10.460

5.  Diabetes Technology and Therapy in the Pediatric Age Group.

Authors:  David M Maahs; Laya Ekhlaspour; Shlomit Shalitin
Journal:  Diabetes Technol Ther       Date:  2021-06       Impact factor: 7.337

6.  Lower HbA1c in patients with type 1 diabetes and celiac disease who reached celiac-specific antibody-negativity-A multicenter DPV analysis.

Authors:  Katrin Nagl; Esther Bollow; Susanne Liptay; Joachim Rosenbauer; Sibylle Koletzko; Angeliki Pappa; Andrea Näke; Elke Fröhlich-Reiterer; Christian Döring; Johannes Wolf; Peter Salfeld; Nicole Prinz
Journal:  Pediatr Diabetes       Date:  2019-08-26       Impact factor: 4.866

7.  Effectiveness and cost-effectiveness of guided Internet- and mobile-based CBT for adolescents and young adults with chronic somatic conditions and comorbid depression and anxiety symptoms (youthCOACHCD): study protocol for a multicentre randomized controlled trial.

Authors:  Frederike Lunkenheimer; Matthias Domhardt; Agnes Geirhos; Reinhold Kilian; Annabel S Mueller-Stierlin; Reinhard W Holl; Thomas Meissner; Kirsten Minden; Morten Moshagen; Ramona Ranz; Cedric Sachser; Doris Staab; Petra Warschburger; Harald Baumeister
Journal:  Trials       Date:  2020-03-12       Impact factor: 2.279

8.  Diabetic Ketoacidosis at Manifestation of Type 1 Diabetes in Childhood and Adolescence—Incidence and Risk Factors.

Authors:  Hugo Segerer; Michael Wurm; Julia M Grimsmann; Beate Karges; Andreas Neu; Marina Sindichakis; Katharina Warncke; Axel Dost; Reinhard W Holl
Journal:  Dtsch Arztebl Int       Date:  2021-06-04       Impact factor: 5.594

9.  Hemoglobin A1c Patterns of Youth With Type 1 Diabetes 10 Years Post Diagnosis From 3 Continents.

Authors:  Jennifer L Sherr; Anke Schwandt; Helen Phelan; Mark A Clements; Reinhard W Holl; Paul Z Benitez-Aguirre; Kellee M Miller; Joachim Woelfle; Thomas Dover; David M Maahs; Elke Fröhlich-Reiterer; Maria E Craig
Journal:  Pediatrics       Date:  2021-08       Impact factor: 9.703

10.  Temporal trends in diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continents.

Authors:  Valentino Cherubini; Julia M Grimsmann; Karin Åkesson; Niels H Birkebæk; Ondrej Cinek; Klemen Dovč; Rosaria Gesuita; John W Gregory; Ragnar Hanas; Sabine E Hofer; Reinhard W Holl; Craig Jefferies; Geir Joner; Bruce R King; Elizabeth J Mayer-Davis; Alexia S Peña; Birgit Rami-Merhar; Ulrike Schierloh; Torild Skrivarhaug; Zdenek Sumnik; Jannet Svensson; Justin T Warner; Nataša Bratina; Dana Dabelea
Journal:  Diabetologia       Date:  2020-05-08       Impact factor: 10.460
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.